HBV DNA and HBsAg: Early Prediction of Response to Peginterferon α-2a in HBeAg-Negative Chronic Hepatitis B

Objective: The proportion of hepatitis e antigen (HBeAg)-negative chronic hepatitis B (CHB) patients in China has increased rapidly. However, the response of these patients to peginterferon (peg-IFN) treatment is poor, and the antiviral treatment strategies are inconsistent. This study aimed to inve...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chong, Yang, Zhengrong, Wang, Ziyi, Dou, Xiaoguang, Sheng, Qiuju, Li, Yanwei, Han, Chao, Ding, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053355/
https://www.ncbi.nlm.nih.gov/pubmed/32132873
http://dx.doi.org/10.7150/ijms.39775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053355/
https://www.ncbi.nlm.nih.gov/pubmed/32132873
http://dx.doi.org/10.7150/ijms.39775

Ejemplares similares